Medication changes reveal hidden pancreatic cancer cases before symptoms appear

Researchers have identified that shifts in patient medication patterns precede a pancreatic cancer diagnosis, potentially offering a new early-warning signal. The finding could reshape screening strategies and insurance data analysis, giving clinicians and health systems a measurable indicator to flag high-risk patients months before clinical symptoms emerge.

Originaltitel: Pancreatic cancer is associated with medication changes prior to clinical diagnosis